ALLIANCEBERNSTEIN L.P. - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$553,000
-12.1%
162,790
-2.7%
0.00%
Q2 2018$629,000
+0.3%
167,310
+9.1%
0.00%
Q1 2018$627,000
-2.3%
153,350
+11.0%
0.00%
Q4 2017$642,000
-57.5%
138,150
-35.0%
0.00%
-100.0%
Q3 2017$1,510,000
+8.9%
212,640
+11.0%
0.00%0.0%
Q2 2017$1,386,000
+63.4%
191,650
+39.2%
0.00%0.0%
Q1 2017$848,000
-3.1%
137,640
-7.8%
0.00%0.0%
Q4 2016$875,000
+10.3%
149,3400.0%0.00%0.0%
Q3 2016$793,000
-25.6%
149,340
-7.3%
0.00%0.0%
Q2 2016$1,066,000
+41.8%
161,0400.0%0.00%0.0%
Q1 2016$752,000
-15.7%
161,040
-8.8%
0.00%0.0%
Q4 2015$892,000
+43.6%
176,5400.0%0.00%0.0%
Q3 2015$621,000
-64.8%
176,540
-0.1%
0.00%0.0%
Q2 2015$1,763,000
-22.3%
176,700
-0.9%
0.00%
-50.0%
Q1 2015$2,270,000
-9.2%
178,300
+0.9%
0.00%0.0%
Q4 2014$2,500,000
-0.3%
176,700
-3.1%
0.00%0.0%
Q3 2014$2,507,000
-10.6%
182,3000.0%0.00%0.0%
Q2 2014$2,804,000
+8.6%
182,300
+20.3%
0.00%0.0%
Q1 2014$2,583,000
+31.4%
151,600
-0.2%
0.00%0.0%
Q4 2013$1,966,000
+29.9%
151,839
+1.4%
0.00%
+100.0%
Q3 2013$1,513,000
+35.2%
149,802
+0.0%
0.00%0.0%
Q2 2013$1,119,000149,8000.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders